These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 6438583)

  • 1. In vitro sensitivity and resistance of cultured human squamous carcinoma cells to cis-platinum and methotrexate.
    Spiegel J; Carey TE; Shimoura S; Krause CJ
    Otolaryngol Head Neck Surg; 1984 Oct; 92(5):524-31. PubMed ID: 6438583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiparametric flow cytometry of human squamous cell carcinoma lines from the head and neck.
    Wustrow TP; Raffael A; Valet G
    Otolaryngol Head Neck Surg; 1988 Jun; 98(6):552-7. PubMed ID: 3138611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Collateral methotrexate resistance in cultured human head and neck carcinoma cells selected for resistance to cis-diamminedichloroplatinum(II).
    Rosowsky A; Wright JE; Cucchi CA; Flatow JL; Trites DH; Teicher BA; Frei E
    Cancer Res; 1987 Nov; 47(22):5913-8. PubMed ID: 3664492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Experimental study of CF chemotherapy, combined with another one chemotherapeutic drug against head and neck cancer cell lines].
    Tsukuda M; Mochimatsu I; Kokatsu T; Ito K; Furukawa S; Inoue T; Watanabe S; Sawaki S
    Gan To Kagaku Ryoho; 1992 Apr; 19(4):553-6. PubMed ID: 1373052
    [No Abstract]   [Full Text] [Related]  

  • 5. Correlation of Notch1 expression and activation to cisplatin-sensitivity of head and neck squamous cell carcinoma.
    Zhang ZP; Sun YL; Fu L; Gu F; Zhang L; Hao XS
    Ai Zheng; 2009 Feb; 28(2):100-3. PubMed ID: 19550121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor responsiveness of squamous cell carcinoma to cisplatin.
    Stiernberg CM; Valyi-Nagy K; Hale PE; Quinn FB; Bailey BJ
    Laryngoscope; 1986 Jul; 96(7):758-62. PubMed ID: 3724327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotypic heterogeneity in cultured human head and neck squamous cell carcinoma lines with low-level methotrexate resistance.
    Rosowsky A; Wright JE; Cucchi CA; Lippke JA; Tantravahi R; Ervin TJ; Frei E
    Cancer Res; 1985 Dec; 45(12 Pt 1):6205-12. PubMed ID: 2415240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II study of methotrexate, vinblastine, doxorubicin, and cisplatin in patients with squamous cell carcinoma of the upper respiratory or alimentary passages of the head and neck.
    Okuno SH; Mailliard JA; Suman VJ; Edmonson JH; Creagan ET; Nair S; Levitt R; Kugler JW
    Cancer; 2002 Apr; 94(8):2224-31. PubMed ID: 12001121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative study of the sensitivity of head and neck cell lines to methotrexate (MTX) and the analog 10-ethyl, 10-deazaaminopterin (10-EdAM).
    Brown DH; Braakhuis BJ; Van Dongen GA; Snow GB
    Otolaryngol Head Neck Surg; 1990 Jan; 102(1):20-5. PubMed ID: 2106113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacodynamics of cisplatin in human head and neck cancer: correlation between platinum content, DNA adduct levels and drug sensitivity in vitro and in vivo.
    Welters MJ; Fichtinger-Schepman AM; Baan RA; Jacobs-Bergmans AJ; Kegel A; van der Vijgh WJ; Braakhuis BJ
    Br J Cancer; 1999 Jan; 79(1):82-8. PubMed ID: 10408697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I trial of retinoic acid and cis-platinum for advanced squamous cell cancer of the head and neck based on experimental evidence of drug synergism.
    Weisman RA; Christen R; Los G; Jones V; Kerber C; Seagren S; Glassmeyer S; Orloff LA; Wong W; Kirmani S; Howell S
    Otolaryngol Head Neck Surg; 1998 May; 118(5):597-602. PubMed ID: 9591856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of platinum-drug cytotoxicity in a human head and neck squamous cell carcinoma line and its platinum-resistant variant by liposomal amphotericin B and phospholipase A2-II.
    Ferguson PJ; Currie C; Vincent MD
    Drug Metab Dispos; 1999 Dec; 27(12):1399-405. PubMed ID: 10570020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promising long-term results with attenuated adverse effects by methotrexate-containing sequential chemoradiation therapy in locally advanced head and neck squamous cell carcinoma.
    Tsai TL; Chu PY; Tai SK; Wang YF; Yang MH; Wang LW; Lirng JF; Chang SY
    Jpn J Clin Oncol; 2011 Oct; 41(10):1182-93. PubMed ID: 21862506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical experiences with in vitro testing of chemotherapeutic agents].
    Axhausen M; Matthias R
    HNO; 1985 Aug; 33(8):374-6. PubMed ID: 2412996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antisense cyclin D1 enhances sensitivity of head and neck cancer cells to cisplatin.
    Wang MB; Yip HT; Srivatsan ES
    Laryngoscope; 2001 Jun; 111(6):982-8. PubMed ID: 11404608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Experiences using combination chemotherapy with cis-platinum, bleomycin and methotrexate in the management of advanced squamous cell carcinomas of the head and neck (author's transl)].
    Jahnke V
    HNO; 1980 Dec; 28(12):405-8. PubMed ID: 6161913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth and chemosensitivity of human head and neck cancers implanted under the kidney capsule of cyclosporine-immunosuppressed mice.
    Bennett JA; Parnes SM; DeConti RC
    Ann Otol Rhinol Laryngol; 1989 Jun; 98(6):455-60. PubMed ID: 2729831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced membrane protein associated with resistance of human squamous carcinoma cells to methotrexate and cis-platinum.
    Bernal SD; Speak JA; Boeheim K; Dreyfuss AI; Wright JE; Teicher BA; Rosowsky A; Tsao SW; Wong YC
    Mol Cell Biochem; 1990 Jun; 95(1):61-70. PubMed ID: 2195318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation and molecular characterization of head and neck squamous cell lines of fanconi anemia patients.
    van Zeeburg HJ; Snijders PJ; Pals G; Hermsen MA; Rooimans MA; Bagby G; Soulier J; Gluckman E; Wennerberg J; Leemans CR; Joenje H; Brakenhoff RH
    Cancer Res; 2005 Feb; 65(4):1271-6. PubMed ID: 15735012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. STI-571 (Gleevec) potentiates the effect of cisplatin in inhibiting the proliferation of head and neck squamous cell carcinoma in vitro.
    Wang-Rodriguez J; Lopez JP; Altuna X; Chu TS; Weisman RA; Ongkeko WM
    Laryngoscope; 2006 Aug; 116(8):1409-16. PubMed ID: 16885745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.